Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gaucher disease]

T Ohashi1

  • 1Jikei University School of Medicine, Department of Pediatrics

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Gaucher disease is a rare inherited metabolic disorder caused by glucocerebrosidase deficiency. Current treatments are limited, but gene therapy offers new hope for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurements of Strong-Interaction Effects in Kaonic-Helium Isotopes at Sub-eV Precision with X-Ray Microcalorimeters.

Physical review letters·2022
Same author

Perirenal fat thickness as a predictor of postoperative complications after laparoscopic distal gastrectomy for gastric cancer.

BJS open·2020
Same author

Verrucous variant of pemphigus foliaceus.

Clinical and experimental dermatology·2019
Same author

Successful treatment with dapsone for lupus profundus accompanied by xanthomatous reaction.

Clinical and experimental dermatology·2018
Same author

A glycomics approach to discover novel renal biomarkers in birds by administration of cisplatin and diclofenac to chickens.

Poultry science·2018
Same author

Koebner Phenomenon In Sweet's Syndrome.

Actas dermo-sifiliograficas·2017
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Context:

  • Gaucher disease is an inherited metabolic disorder resulting from deficient glucocerebrosidase activity.
  • This deficiency leads to the accumulation of glucocerebroside in macrophages, primarily in the bone marrow.
  • Three distinct clinical phenotypes are recognized, varying by disease onset and neurological involvement.

Purpose:

  • To provide an overview of Gaucher disease, including its pathophysiology, diagnosis, and current therapeutic limitations.
  • To highlight the emerging potential of gene therapy for treating Gaucher disease.

Summary:

  • Gaucher disease is characterized by reduced glucocerebrosidase enzyme activity, leading to glucocerebroside buildup.
  • Diagnosis relies on enzymatic assays in tissues like white blood cells (WBCs) and fibroblasts, with molecular diagnostics also available.

Related Experiment Videos

  • Differentiating between the three clinical phenotypes remains challenging, and existing treatments like bone marrow transplantation and enzyme infusion have limitations.

    • Impact:

    • Gene therapy, utilizing the transfer of therapeutic genes to hematopoietic stem cells, has recently initiated clinical trials in the USA.
    • This advancement holds promise for a more effective and potentially curative treatment for Gaucher disease.
    • Further research and clinical application of gene therapy could significantly improve outcomes for individuals affected by this rare metabolic disorder.